According to Taro Pharmaceutical's latest financial reports the company's total liabilities are โฌ0.37 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | โฌ0.37 B | -10.91% |
2022-03-31 | โฌ0.41 B | -31.36% |
2021-03-31 | โฌ0.60 B | 189.15% |
2020-03-31 | โฌ0.20 B | 5.13% |
2019-03-31 | โฌ0.19 B | 10.47% |
2018-03-31 | โฌ0.18 B | -10.57% |
2017-03-31 | โฌ0.20 B | -8.71% |
2016-03-31 | โฌ0.22 B | -25.17% |
2015-03-31 | โฌ0.29 B | 54.21% |
2014-03-31 | โฌ0.19 B | 14.04% |
2013-03-31 | โฌ0.16 B | |
2011-12-31 | โฌ0.17 B | 33.91% |
2010-12-31 | โฌ0.12 B | -33.91% |
2009-12-31 | โฌ0.19 B | -11.49% |
2008-12-31 | โฌ0.22 B | -2.27% |
2007-12-31 | โฌ0.22 B | -20.43% |
2006-12-31 | โฌ0.28 B | -19.89% |
2005-12-31 | โฌ0.35 B | 46.67% |
2004-12-31 | โฌ0.24 B | 13.85% |
2003-12-31 | โฌ0.21 B | 102.68% |
2002-12-31 | โฌ0.10 B | 4.43% |
2001-12-31 | โฌ0.10 B |